Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Dr. Quarraisha Abdool Karim, Hideyo Noguchi Africa Prize Winner, Joins GHIT Fund…
Dr. Abdool Karim serves as co-founder and Associate Scientific Director of the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and holds professorships in Clinical Epidemiology at Columbia University in the United States and in Public Health at the University of KwaZulu-Natal in South Africa. Her groundbreaking research on HIV in South Africa, particularly among adolescent girls, and her leadership in numerous global health initiatives underscore her significant contributions…
PR Newswire
19/09/2024
Advanced Method for Predicting Response to Midostaurin plus Chemotherapy in…
The publication details how mass spectrometry phosphoproteomics was combined with machine learning to identify biomarkers of response to MIC. When applied to two independent retrospective real-world patient test cohorts (n=20) the method predicted MIC response with 83% sensitivity, 100% specificity and HR = 0.005 [95% CI: 0-0.31], greatly outperforming the current FLT3 status-based, stratification method for MIC. The publication details how mass spectrometry phosphoproteomics was combined…
PR Newswire
19/09/2024
Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction featureThe launch will expectedly improve Evaxion's ability to fast and effectively discover AI-derived novel vaccines and is expected to further solidify the strong interest seen in AI-Immunology™ from potential partnersNew data demonstrating the improved performance of EDEN™will be presented today at theEuropean...
Nasdaq GlobeNewswire
19/09/2024
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
Helsinn Group appoints Riccardo Carbucicchio to the Board of DirectorsLugano, Switzerland – September 19, 2024– Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce the appointment of Riccardo Carbucicchio as a new member of its Board of Directors, effective immediately.Riccardo Carbucicchio has extensive experience...
Nasdaq GlobeNewswire
19/09/2024
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen…
Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohortCombination of Ampligen and Imfinzi continues to be generally well-tolerated with no severe adverse events or dose-limiting toxicities OCALA, Fla., Sept.19, 2024(GLOBE NEWSWIRE) -- AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM”) today announced positive preliminary data from the Phase 1b/2 study (“DURIPANC”) evaluating the combination of AIM's Ampligen ®(rintatolimod)...
Nasdaq GlobeNewswire
19/09/2024
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes…
“Alzheimer's disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need for innovative therapeutic approaches is urgent,” commented Howard L. Weiner, M.D., Principal Investigator, Chairman of Tiziana's Scientific Advisory Board and co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital, a founding member of Mass General...
Nasdaq GlobeNewswire
19/09/2024
Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical…
Press ReleaseDr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development AdvisorGeneva, Switzerland – September 19, 2024– STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neurodevelopmental disorders, announced today that Dr. Paulo Fontoura will be joining their drug development team as Chief Scientific and Clinical Development Advisor. Dr. Fontoura will work to support STALICLA's...
Nasdaq GlobeNewswire
19/09/2024
Pudu Robotics Unveils their PUDU D7 Semi-Humanoid Robot, Showcasing Breakthrough…
In May of this year, Pudu Robotics introduced the "semi-humanoid robot" concept as part of its long-term strategic vision for the service robotics industry. Pudu Robotics focuses on developing three distinct categories of robots: specialized robots designed for specific tasks, semi-humanoid robots built for adaptable and versatile applications, and fully humanoid robots for complex human interactions. In May of this year, Pudu Robotics introduced the "semi-humanoid robot"…
PR Newswire
19/09/2024
TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide
The refreshed mission—to empower partners to advance treatments that promote global health and well-being—marks a deepened focus on transforming patient care through innovative drug development. With patient-centered care at its core, TFS reinforces its role as a CRO that not only supports the pharmaceutical industry but drives meaningful impact on global health. The refreshed mission—to empower partners to advance treatments that promote global health and well-being—marks a deepened focus on...
PR Newswire
19/09/2024
ILC Dover's SCape CO/CBRN 30 Escape Respirator Receives CE and UKCA…
Key features of the SCape CO/CBRN 30 include: Key features of the SCape CO/CBRN 30 include: "Earning the CE and UKCA certifications reflects our unwavering commitment to excellence and underscores our dedication to prioritizing customer safety," sharedMark Gruber, General Manager of PPE, Packaging, and Safety (PP&S) at ILC Dover. "The SCape CO/CBRN 30 is a breakthrough in personal protective equipment, featuring an automatic blower system and robust protection capabilities...
PR Newswire
19/09/2024
Renovos Biologics strengthens its Board's US expertise with the appointment of…
Dr Ferrara is managing partner of Hypoid Ventures, LLC, a technology consulting firm. She previously founded OrthoKinetic Technologies and OrthoKinetic Testing Technologies, LLC — two highly successful companies specialising in medical device evaluation, strategic positioning, and regulatory success, which were later acquired. Dr Ferrara is managing partner of Hypoid Ventures, LLC, a technology consulting firm. She previously founded OrthoKinetic Technologies and OrthoKinetic Testing...
PR Newswire
19/09/2024
Ada Health and Santéclair extend partnership, providing AI-powered care…
Ada Health's highly accurate AI assessment technology was first integrated into MySantéclair, Santéclair's digital health platform, in 2021. After using Ada on MySantéclair, users are navigated to the most appropriate and cost-effective virtual or in-person services based on their likely condition. Tens of thousands of members have already utilized Ada through MySantéclair, with 23% using Ada more than once. The service is available 24/7, allowing rapid healthcare advice and supporting access to…
PR Newswire
19/09/2024
Implantica conducts first national RefluxStop™ User meeting with 21…
Dr. med. Moustafa Elshafei, a leading anti-reflux surgeon in Germany, led the surgical training for 21 experienced anti-reflux surgeons from leading reflux specialized centers in Italy. Empowered by his extensive experience with RefluxStop™ and other surgical treatments, Dr. med. Elshafei says, "The enthusiasm we saw for Refluxstop™ in Italy is a testament to the incredible need for this innovative treatment for GERD. Countless patients will finally have the option of a surgical treatment…
PR Newswire
19/09/2024
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System…
Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injury ™System to restore lower limb mobility after SCI. The ARC-BCI System combines the investigational ONWARD ARC-IM ®System (an implanted technology that delivers targeted stimulation to the spinal cord) with the investigational WIMAGINE ®BCI fromCEA-Clinatecto create a DigitalBridge ™across the injured spinal cord. The implant procedure was performed on September 12, 2024, by...
Nasdaq GlobeNewswire
19/09/2024
XRP Healthcare Magazine Unveils Groundbreaking AI Development in 4th Issue…
The XRPH AI chatbot stands out for its ability to generate custom personal training programs based on users' weight, height, ethnicity, injuries, and diet preferences. It also provides advice on meditation techniques, nutrition, and cutting-edge treatments for terminal illnesses, such as cancer. XRP Healthcare has a dedicated AI development team continuously working to evolve the chatbot, with more innovations planned for release later this quarter. ChairmanWhitney Lynncommented,...
PR Newswire
19/09/2024
Basilea enters into agreement with BARDA to develop novel antifungals and…
Initial funding of USD 29 million to support development of Basilea's clinical stage first-in-class antifungals, fosmanogepix and BAL2062Multi-year Other Transaction Agreement (OTA) allows for potential funding of up to approximately USD 268 million to develop antifungal and antibacterial assets Increasing FY 2024 financial guidance on total revenue, operating result and net profit Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, September 19, 2024 Basilea...
Nasdaq GlobeNewswire
19/09/2024
Positive phase III results show Xofluza significantly reduces the transmission…
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment of a respiratory viral illness has demonstrated a transmission reduction benefit in a global phase III study Reducing the spread of infection in the household could help limit transmission within communities and societies, easing the burden of both seasonal and pandemic influenza on...
Nasdaq GlobeNewswire
19/09/2024
Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net…
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024-Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its provisional half-year and second quarter net results have increased significantly in 2024 compared to 2023 and first quarter 2024 results primarily due to the sale of part of its business to...
Nasdaq GlobeNewswire
19/09/2024
Axial Spondyloarthritis Market - US to Have the Lion's Share Among the 7MM |…
The condition tends to run in families and is divided into two types: ankylosing spondylitis, or radiographic axSpA, where damage to the sacroiliac joints and spine is visible on X-rays, and non-radiographic axSpA, where damage might not be seen on X-rays but can be identified using MRI. Typically, it starts between the ages of 20 and 40, is more frequent in men, though non-radiographic axSpA can affect both genders equally. The condition tends to run in families and is divided into two…
PR Newswire
18/09/2024
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune system before checkpoint therapySeveral clinical milestones expected over the next 12-18 months including updated data in pancreatic, and head and neck cancer, and initial data in esophageal and lung cancer€66.3 million in cash and cash equivalents as of June 30, 2024, with a cash runway...
Nasdaq GlobeNewswire
18/09/2024
NTG Nordic Transport Group acquires ITC Logistics
Company announcement no. 8 – 24 18 September 2024 NTG Nordic Transport Groupacquires ITC Logistics NTG Germany GmbH (“NTG”), a fully owned subsidiary of NTG Nordic Transport Group A/S, has signed an agreement to acquire German-based ITC Logistics GmbH.ITC specialises in delivering bespoke road and logistics solutions to a portfolio of long-standing customers. ITC is well positioned as a full-service, end-to-end solutions provider offering groupage, FTL, LTL, comprehensive logistics...
Nasdaq GlobeNewswire
18/09/2024
China eyes multiple records as it hosts the FDI World Dental Congress in…
China's emphasis on health has evolved significantly in recent years, particularly in oral care, positioning it as a key growth market in the global healthcare landscape. In 2023, the scale of China's oral care industry reached approx. 49.15 billion yuan. Even niche products like mouthwash are becoming essential items. The trend is supported by a rising number of consumers investing in premium products and services. China'semphasis on health has evolved significantly in recent years,...
PR Newswire
18/09/2024
Convatec UK launches new Esteem Body™ with Leak Defense™
Between 28 September and 1 October 2024, the Association of Stoma Care Nurses (ASCN) and the World Council of Enterostomal Therapists® will jointly host the international congress in Glasgow, where Convatec will reveal the new Esteem Body™ with Leak Defense™. Between 28 September and1 October 2024, the Association of Stoma Care Nurses (ASCN) and the World Council of Enterostomal Therapists® will jointly host the international congress inGlasgow, where Convatec will reveal the new...
PR Newswire
18/09/2024
Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at…
Prime determinants of growth Prime determinants of growth Increasing prevalence of autoimmune diseases, surge in technological advancements, and rise in awareness about early diagnosis are the major factors that drive the growth of the autoimmune disease testing market growth. However, the stringent regulatory requirements and approval processes restrict market growth. Moreover, growth opportunities in emerging markets offer remunerative opportunities for the expansion of the global...
PR Newswire
18/09/2024
Altri Comunicati
